• Quick Order

  • 0

    CART

    • Account

Launch of New GMP Oligo Manufacturing Facility

Eurofins Genomics US Expands Capabilities with New GMP Oligonucleotide Manufacturing Facility

Eurofins Genomics US is proud to announce the opening of its state-of-the-art Good Manufacturing Practice (GMP) oligonucleotide manufacturing facility. This new facility marks a significant milestone in our commitment to excellence and innovation in genomics, enhancing our ability to meet the growing demand for high-quality oligonucleotides for both research and regulated applications.

READ THIS

Eurofins Genomics Launches AAV Sequencing

7/16/24 | 5 Min Read

Eurofins Genomics now offers affordable, fast AAV sequencing using the Oxford Nanopore (ONT) sequencing platform, which is known for providing real-time, long-read sequencing. Traditional sequencing methods often struggle with the repetitive and GC-rich regions of AAV genomes, whereas ONT traverses these complexities, ensuring complete and accurate genome assemblies.

READ THIS

Eurofins Genomics US Extends Service Offering for Nanopore Sequencing with Bacterial Genome Sequencing

12/18/23 l 5 min read

Bacterial Genome sequencing is designed for the comprehensive analysis of entire genomes. It involves the sequencing and assembly of genomic DNA (gDNA) derived from a clonal population, specifically a singular bacterial species. Leveraging cutting-edge long-read sequencing technology from Oxford Nanopore Technologies (ONT), this service encompasses the following key components:

READ THIS

Eurofins Genomics US Adds Amplicon Sequencing to ONT Service Portfolio

11/11/23 l 5 min read

Amplicon sequencing, a technique focused on the targeted amplification of specific DNA regions, benefits significantly from the long-read capabilities of Oxford Nanopore sequencing. Unlike short-read technologies, such as those based on Illumina platforms, Oxford Nanopore sequencing generates reads of exceptional length. This feature is particularly advantageous for amplicon sequencing, as it enables the sequencing of entire target regions in a single, contiguous read.

READ THIS

Nanopore Sequencing Service | Fast & Accurate Results

02/09/23 | 5 Min Read

Eurofins Genomics US, the global leader in sequencing, launches a revolutionary new, low cost, whole plasmid sequencing service with same-day results. The company expanded its already massive sequencing infrastructure in Louisville to include Nanopore sequencing capabilities.

READ THIS

Eurofins Announces Partnership with Ginkgo Bioworks for Innovative SARS-CoV-2 Waste Water Testing in U.S. Airports

02/10/23 | 10 Min Read

Eurofins Genomics has partnered with Concentric by Ginkgo Bioworks on an expanded program that will serve as an early warning system to detect new or emerging SARS-CoV-2 variants, and can facilitate response to future travel-associated outbreaks and pandemics. It provides a pulse of COVID-19 cases and the arrival of variants among international travelers, delivering important data as the country monitors the global COVID-19 situation.

READ THIS

DAF Awards $30 Million Contract to Eurofins Genomics to Expand Oligonucleotide (DNA) Capacity for Diagnostic Testing

10/08/21 | 4 Min Read

The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents used in COVID-19 diagnostic tests.

 

READ THIS